| Catalog_no |
ADMC1321 |
| Product_name |
Atrasentan hydrochloride |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
3340.00/10060.00/18120.00 |
| Specificity |
Target: Endothelin Receptor. Fields: Atrasentan Hcl(A-147627) is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer. |
| Dilution |
IC50: 0.055 nM (ETA) |
| Purification |
>98% |
| Concentration |
靶点：Endothelin Receptor;IC50： 0.055 nM (ETA) |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
ABT-627; ABT627; ABT 627; Abbott 147627 |
| Molecular Weight |
547.08 |
| Notes |
Atrasentan Hcl(A-147627) is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer. |
| Instructions |
 查看与下载 |
